Dopagon Tablets

Dopagon Tablets

Description:

Dopagon 2.5 mg tablets are a prescription dopamine agonist medicine containing bromocriptine, an ergot-derived agent used primarily in the management of Parkinson’s disease and conditions associated with hyperprolactinemia (elevated prolactin levels). By stimulating dopamine D2 receptors, Dopagon helps improve motor symptoms in Parkinsonism and reduces prolactin secretion from the pituitary gland. It is indicated for adults under specialist medical supervision and should be used strictly according to a doctor’s prescription.

Indications:

• Adjunctive treatment of Parkinson’s disease and Parkinsonism to help improve tremor, rigidity, and bradykinesia.
• Treatment of amenorrhea and galactorrhea associated with hyperprolactinemia.
• Management of hyperprolactinemic disorders, including some cases of infertility related to high prolactin levels (under specialist care).
• Adjunctive treatment of acromegaly as directed by an endocrinologist.
• Supportive therapy in hepatic encephalopathy as prescribed by a specialist.
• Management of premenstrual syndrome (PMS) in selected patients as advised by a physician.
• Adjunctive treatment in Cushing’s syndrome under endocrinology supervision.
• Suppression of established lactation when medically indicated and prescribed by a doctor.

Active Ingredients / Key Components:

• Bromocriptine mesylate – 2.5 mg per tablet

Other inactive ingredients (excipients) are not specified in the available information (For full ingredient information, please check the product leaflet or the manufacturer’s official website.). Exact excipient composition and concentrations are unavailable.

Dosage & Administration / How to Use:

• General dosing: Dosage must be individualized by the treating physician based on the indication, patient response, and tolerability.
• Parkinson’s disease: Treatment is usually started with a low dose (for example 1.25–2.5 mg daily) and gradually increased as tolerated. Typical maintenance doses are higher and divided throughout the day. Exact regimen must be determined by a neurologist.
• Hyperprolactinemia, amenorrhea, galactorrhea, PMS, suppression of lactation: Therapy is usually initiated with a low dose (e.g., 1.25–2.5 mg once or twice daily) and adjusted according to prolactin levels and clinical response as directed by the doctor.
• Acromegaly, Cushing’s syndrome, hepatic encephalopathy: Doses are individualized and often higher; must be prescribed and closely monitored by a specialist.
• Administration: Take tablets by mouth, preferably with food to reduce gastrointestinal side effects such as nausea and vomiting.
• Swallow the tablet whole with a glass of water. Do not crush or chew unless your doctor or pharmacist specifically advises otherwise.
• Take at the same time(s) each day to maintain consistent blood levels.
• If you miss a dose, take it as soon as you remember unless it is almost time for the next dose. Do not double the dose to make up for a missed one.
• Do not stop taking Dopagon suddenly without consulting your doctor, especially in Parkinson’s disease, as symptoms may worsen.

Clinical Benefits:

• Improves motor function in Parkinson’s disease by stimulating dopamine receptors, helping reduce tremor, stiffness, and slowness of movement.
• Reduces elevated prolactin levels, helping manage amenorrhea, galactorrhea, and certain infertility issues related to hyperprolactinemia.
• Helps control symptoms of acromegaly by decreasing growth hormone levels when used as adjunctive therapy.
• Supports endocrine balance in conditions such as premenstrual syndrome and Cushing’s syndrome under specialist guidance.
• Assists in suppression of established lactation when breastfeeding must be stopped for medical reasons.
• May contribute to improved quality of life in patients with Parkinsonism and prolactin-related disorders when used as part of a comprehensive treatment plan.

Warnings & Contraindications:

• Contraindicated in patients with known hypersensitivity to bromocriptine, other ergot alkaloids, or any tablet component.
• Contraindicated in patients with uncontrolled hypertension, severe cardiovascular disease, or a history of coronary artery disease unless the potential benefit outweighs the risk and is closely monitored.
• Use with extreme caution in patients with a history of psychotic disorders, as dopamine agonists may exacerbate psychosis.
• May cause hypotension (low blood pressure), especially on initiation or dose increase; stand up slowly from sitting or lying positions.
• Can cause somnolence and sudden sleep onset; avoid driving or operating machinery until you know how the medicine affects you.
• Use with caution in patients with liver impairment or kidney disease; dose adjustment and monitoring may be required.
• Inform your doctor if you have a history of peptic ulcer, gastrointestinal bleeding, or severe vascular disease.
• Long-term use of ergot derivatives has been associated with fibrotic complications (e.g., pulmonary, retroperitoneal, or cardiac valvular fibrosis); periodic monitoring may be required for long-term therapy.
• Consult your doctor before use if pregnant or planning pregnancy; bromocriptine is sometimes used in fertility treatment but must be strictly supervised by a specialist.
• Breastfeeding: Bromocriptine suppresses lactation and is generally not recommended if you intend to breastfeed.
• Inform your doctor about all medicines you are taking, including antihypertensives, other dopamine agonists, antipsychotics, macrolide antibiotics, and antifungals, due to potential interactions.
• Not intended for self-medication; use only under medical supervision.
• Keep out of reach of children.

Side Effects:

• Common side effects: Nausea, vomiting, abdominal discomfort, constipation, dizziness, headache, fatigue, and low blood pressure (especially when standing).
• Less common side effects: Nasal congestion, dry mouth, leg cramps, confusion, insomnia, or vivid dreams.
• Serious side effects (seek medical attention immediately): Chest pain, severe or persistent headache, visual disturbances, shortness of breath, swelling of legs, signs of heart problems, severe abdominal pain, black or bloody stools, sudden changes in behavior, hallucinations, or severe mood changes.
• Stop the medication and contact your doctor if you experience symptoms suggestive of fibrosis (persistent cough, difficulty breathing, unexplained weight loss, back or flank pain, swelling of legs) or stroke (sudden weakness, speech difficulty, facial drooping).
• This is not a complete list of side effects. Report any unusual or bothersome symptoms to your healthcare provider.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children.

Specifications:

• Active ingredient: Bromocriptine mesylate 2.5 mg per tablet.
• Form: Oral tablet.
• Pack size: 20 tablets per pack (exact count confirmed: 20 tab).
• Intended use: Prescription medicine for Parkinson’s disease and hyperprolactinemic conditions under medical supervision.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.